Pillstats
Rx only · Cream · Topical

Calcipotriene

Calcipotriene

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCD05AX02
RxCUI (US)29365
US makers3 labelers
Packages6
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.346$0.691$1.04$1.38Dec 2025Apr 2026Jul 2026
$1.080
Latest avg · Jul 22, 2026
-10%
Since Dec 17, 2025
3
Active US suppliers
67%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

5.8K12K17K23K2025 Q12025 Q22025 Q32025 Q42026 Q1
19K
Rx · 2026 Q1
1.5M
Units dispensed
+1%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
NorthStar Rx LLCunknown2SUPPLYING
Prasco Laboratoriesunknown2SUPPLYING
Glenmark Pharmaceuticals Inc., USAunknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jan 19, 2017
    RECALLRecall (Class II): Calcipotriene Cream 0.0005%, packaged in a) 60g tube, (NDC 66993-877-61), b) 120g tube (NDC 66993-877-78), Rx Only, Ma…

    Incorrect/Undeclared excipients: inadvertent omission of a drug excipient from the the Authorized Generic label and also a warning regarding contact dermatitis from the brand product labeling not being incorporated into the Authorized Generic labeling. — Recalling firm: LEO PHARMA INC — U.S. Nationwide